Showing results (341-350 of 608) with videos related to

Sort By:
Pageof 61
Allergy|April 29, 2023
The One Health approach for allergic diseases and asthmaMarek Jutel, Giselle S Mosnaim, Jonathan A Bernstein, et al.
American Journal of Medical Genetics. Part A|October 20, 2021
Variable clinical severity in TANGO2 deficiency: Case series and literature reviewJennifer Schymick, Peter Leahy, Tina Cowan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 12, 2016
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry DataMarc A Riedl, Anette Bygum, William Lumry, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 9, 2026
Donidalorsen for hereditary angioedema: Long-term results from a 4-year phase 2 open-label extension studyMichael E Manning, Mats de Lange, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology|February 26, 2026
A Randomized Dose-Finding Study of Anti-KIT Barzolvolimab in Patients with Chronic Spontaneous UrticariaMartin Metz, Essack Mitha, Jeffrey Leflein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 8, 2025
Hereditary Angioedema With Normal C1 Inhibitor: A Quarter Century of Forward Progress and Persisting ObstaclesSandra C Christiansen, Aleena Banerji, Jonathan A Bernstein, et al.
The Patient|January 28, 2025
Assessing Preferences of Patients with Chronic Spontaneous Urticaria for Injectable Treatment ProfilesAna Maria Giménez-Arnau, Maria-Magdalena Balp, Andrii Danyliv, et al.
Allergy and Asthma Proceedings|May 16, 2015
Current state of hereditary angioedema management: a patient surveyAleena Banerji, Paula Busse, Sandra C Christiansen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 29, 2014
Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trialMarc A Riedl, Jonathan A Bernstein, Henry Li, et al.
Allergy|July 21, 2021
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE StudyAleena Banerji, Jonathan A Bernstein, Douglas T Johnston, et al.
Pageof 61